Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.

Victor
By -
0 minute read
0
George Grigoiadis et al. published in Annals of Hematology.

Read article here.

Post a Comment

0Comments

Post a Comment (0)
Today | 7, April 2025